sec filing
RN
NASDAQ · RNAZ
TransCode Therapeutics, Inc.
Healthcare · Biotechnology
$1.69
Up+$0.00 (+0.00%)
Updated Sep 13, 2026, 3:31 PM
SID Score
2.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.55M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $1.63 – $20.99
- Volume
- 11.45K
- Avg. volume
- 142.25K
Price performance
RNAZ price history
1M range · 19 trading sessions · Daily adjusted prices
RNAZ closed at $1.69 after 19 trading sessions, down 46.52% for the selected period.
- Last close
- $1.69
- Period change
- -46.52%
- Period low
- $1.69
- Period high
- $3.24
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.68 | $1.74 | $1.6265 | $1.69 | 11.45K |
| Sep 10, 2026 | $1.72 | $1.83 | $1.69 | $1.69 | 26.09K |
| Sep 9, 2026 | $1.86 | $1.95 | $1.75 | $1.78 | 30.94K |
| Sep 8, 2026 | $1.98 | $2.03 | $1.88 | $1.89 | 37.79K |
| Sep 4, 2026 | $2.18 | $2.18 | $2.05 | $2.06 | 10.62K |
| Sep 3, 2026 | $2.27 | $2.27 | $2.02 | $2.155 | 69.97K |
| Sep 2, 2026 | $2.06 | $2.12 | $2.01 | $2.01 | 22.51K |
| Sep 1, 2026 | $2.08 | $2.3498 | $2.04 | $2.06 | 98.17K |
| Aug 31, 2026 | $2.10 | $2.28 | $1.8318 | $2.10 | 838.25K |
| Aug 28, 2026 | $2.24 | $2.3453 | $2.09 | $2.18 | 38.03K |
| Aug 27, 2026 | $2.35 | $2.4085 | $2.27 | $2.28 | 27.62K |
| Aug 26, 2026 | $2.58 | $2.58 | $2.24 | $2.34 | 24.25K |
| Aug 25, 2026 | $2.74 | $2.873 | $2.40 | $2.53 | 138.12K |
| Aug 24, 2026 | $2.90 | $2.91 | $2.65 | $2.70 | 78.33K |
| Aug 21, 2026 | $2.90 | $3.00 | $2.87 | $2.87 | 42.18K |
| Aug 20, 2026 | $3.121 | $3.28 | $2.87 | $2.97 | 45.69K |
| Aug 19, 2026 | $3.27 | $3.4899 | $3.03 | $3.21 | 76.13K |
| Aug 18, 2026 | $3.00 | $3.37 | $3.00 | $3.24 | 22.06K |
| Aug 17, 2026 | $3.36 | $3.4978 | $2.9432 | $3.16 | 81.26K |
Latest RNAZ news
The latest Smart Investors Daily articles mentioning RNAZ.
Stock researchMarket Activity · Insider Trades
Loading stock research…